Callan Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.07M | Sell |
11,927
-468
| -4% | -$42K | 0.08% | 114 |
|
|
2024
Q4 | $1.23M | Buy |
12,395
+1,770
| +17% | +$176K | 0.09% | 94 |
|
|
2024
Q3 | $1.21M | Sell |
10,625
-355
| -3% | -$40.3K | 0.08% | 105 |
|
|
2024
Q2 | $1.36M | Buy |
10,980
+1,187
| +12% | +$147K | 0.11% | 93 |
|
|
2024
Q1 | $1.29M | Buy |
9,793
+2,077
| +27% | +$274K | 0.11% | 89 |
|
|
2023
Q4 | $841K | Buy |
7,716
+332
| +4% | +$36.2K | 0.08% | 103 |
|
|
2023
Q3 | $760K | Buy |
7,384
+422
| +6% | +$43.4K | 0.08% | 94 |
|
|
2023
Q2 | $803K | Sell |
6,962
-1,134
| -14% | -$131K | 0.09% | 86 |
|
|
2023
Q1 | $861K | Buy |
8,096
+75
| +0.9% | +$7.98K | 0.1% | 83 |
|
|
2022
Q4 | $890K | Buy |
8,021
+3,496
| +77% | +$388K | 0.11% | 82 |
|
|
2022
Q3 | $390K | Buy |
4,525
+598
| +15% | +$51.5K | 0.06% | 89 |
|
|
2022
Q2 | $358K | Hold |
3,927
| – | – | 0.06% | 86 |
|
|
2022
Q1 | $322K | Buy |
3,927
+85
| +2% | +$6.97K | 0.04% | 97 |
|
|
2021
Q4 | $294K | Buy |
3,842
+80
| +2% | +$6.12K | 0.04% | 109 |
|
|
2021
Q3 | $283K | Sell |
3,762
-100
| -3% | -$7.52K | 0.05% | 74 |
|
|
2021
Q2 | $300K | Sell |
3,862
-81
| -2% | -$6.29K | 0.05% | 75 |
|
|
2021
Q1 | $290K | Hold |
3,943
| – | – | 0.05% | 75 |
|
|
2020
Q4 | $308K | Hold |
3,943
| – | – | 0.06% | 73 |
|
|
2020
Q3 | $312K | Hold |
3,943
| – | – | 0.07% | 70 |
|
|
2020
Q2 | $291K | Hold |
3,943
| – | – | 0.07% | 76 |
|
|
2020
Q1 | $289K | Buy |
+3,943
| New | +$289K | 0.09% | 68 |
|